Geen categorie

AiCuris nominates Madam Therapeutics as the first winner of the AiCubator Resident Status in 2022, a corporate innovation accelerator initiative

On Aril 8th 2022, AiCuris announced at the BIOCOM AMR Conference 2022 that it has selected Madam Therapeutics with its unique peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022, a corporate innovation …

AiCuris nominates Madam Therapeutics as the first winner of the AiCubator Resident Status in 2022, a corporate innovation accelerator initiative Read Further

European Commission publishes our screening project for peptides to treat COVID-19 and bacterial infections

In a united spirit to COVID-19 response and to support the European recovery, the European Investment Project Portal (EIPP) and the Commission’s Research Directorate-General (RTD) have again put together their forces and acted as a team to acknowledge COVID-19 projects …

European Commission publishes our screening project for peptides to treat COVID-19 and bacterial infections Read Further